⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
High antipsychotic prescribing (65+)extreme_fills_per_patient
Risk indicators are statistical patterns, not allegations. Learn more
11,216
Total Claims
$871K
Drug Cost
283
Beneficiaries
$3,078
Cost/Patient
Risk Score Breakdown 17/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
High fills per patient+5
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
+620%
Cost per patient vs peers
$3,078 vs $427 avg
+248%
Brand preference vs peers
18.3% vs 5.2% avg
Brand vs Generic
82% generic
Brand: 2,028 claims · $621K
Generic: 9,077 claims · $240K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 375 | $106K |
| Sitagliptin Phosphate | 178 | $51K |
| Dulaglutide | 35 | $35K |
| Brexpiprazole | 50 | $34K |
| Rivaroxaban | 106 | $31K |
| Insulin Aspart | 167 | $29K |
| Insulin Detemir | 103 | $29K |
| Dextromethorphan Hbr/Quinidine | 47 | $26K |
| Risperidone Microspheres | 13 | $25K |
| Insulin Glargine,hum.Rec.Anlog | 74 | $23K |
| Ertapenem Sodium | 46 | $19K |
| Linaclotide | 32 | $18K |
| Sevelamer Carbonate | 64 | $14K |
| Semaglutide | 13 | $13K |
| Pantoprazole Sodium | 348 | $11K |
Prescribing Profile
Patient Profile
75
Avg Age
49%
Female
3.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About